Celiac disease is an autoimmune disorder against the gluten consumed that creates toxins, thereby, destroying the villi. It affects almost 1 percent of the population worldwide.
Gain rich insights into the Celiac disease, its signs, symptoms, causes, and diagnostics tests. Know more about its epidemiological statistics, available treatment scenario, Celiac disease marketed therapies available, and unmet needs in the market through our newsletter.
The newsletter brings an overlay of the Celiac disease market landscape, ongoing clinical trials, and therapies in the pipeline that are expected to transform the Celiac disease market in the next decade.
Know about the major pharma companies in the Celiac disease market landscape, the recent collaborations and agreements, and the happenings at the research front advancing the Celiac disease market landscape.
Subscribe for more.
Also, give it a good read to our latest blog: Celiac Disease: The Hidden Epidemic of Gluten Sensitivity
Know more about What's covered:
- Indication overview
- Signs, symptoms, and diagnosis
- Treatment approaches
- Epidemiological trends
- Unmet needs
- Market insights
- Key Companies
- Clinical trials
- R&D in the field
- Top conferences
- Support from International organizations
- Collaborations and deals in the domain